Who Buys Docusate from India — 158 Importers Behind a $9.3M Market
India's docusate import market is served by 158 active buyers who collectively imported $9.3M across 453 shipments. PL DEVELOPMENTS (UNITED STATES) leads with a 54.3% market share, followed by GERICARE PHARMACEUTICALS CORP. and GENERIC HEALTH. The top 5 buyers together control 78.3% of total import value, reflecting a concentrated buyer landscape.
Docusate buyer data — 158 importers · $9.3M market · 453 shipmentsTransData Nexus · Indian Customs Data
Top Docusate Importers — Ranked by Import Value
PL DEVELOPMENTS (UNITED STATES) is the leading docusate importer from India, holding a 54.3% share of the $9.3M market across 453 shipments from 158 buyers. The top 5 buyers — PL DEVELOPMENTS (UNITED STATES), GERICARE PHARMACEUTICALS CORP. (UNITED STATES), GENERIC HEALTH (AUSTRALIA), GERICARE PHARMACEUTICALS CORP (UNITED STATES), APOTEX AUSTRALIA (AUSTRALIA) — collectively control 78.3% of total import value.
Top Docusate Buyers & Importers
Ranked by import value · 158 active buyers · Indian Customs (DGFT) data
Mar 2026
Top Docusate Buyers & Importers — Ranked by Import Value. 158 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Docusate — and from which countries?
Flow of Docusate exports from India: each country's share and the named importers behind the numbers
Docusate — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 99.4% of global Docusate imports — led by United States (84.6%) with a total trade value of $9.3M across 453 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $7.8M through 184 shipments. This represents a market share of 84.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• PL DEVELOPMENTS - $5.0M (64.2% of country's total business)
• GERICARE PHARMACEUTICALS CORP. - $1.2M (15.0% of country's total business)
• GERICARE PHARMACEUTICALS CORP - $348.7K (4.5% of country's total business)
• GERICARE PHARMACEUTICALS - $145.8K (1.9% of country's total business)
• STRIVE PHARMACEUTICALS - $141.3K (1.8% of country's total business)
• Rest of United States's importers - $995.2K (12.7% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $42.6K, indicating premium pricing strategy compared to the market average of $20.5K.
United States is a key market for Docusate imports, representing 84.6% of total trade value.
The importation of Docusate from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like PL Developments and Gericare Pharmaceuticals Corp. in the United States function as distributors. They procure Docusate in bulk to supply to pharmacies, hospitals, and retailers. Their purchasing patterns are characterized by large, consistent orders to maintain a steady supply chain.
Contract Manufacturers: Companies such as Apotex Australia and Noumed Pharmaceuticals Pty Ltd in Australia act as contract manufacturers. They import Docusate as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement is aligned with production schedules and market demand forecasts, leading to periodic, substantial orders.
Retail Chains: While not explicitly listed among the top buyers, retail chains may also import Docusate directly or through intermediaries to stock their pharmacy outlets. Their purchasing behavior typically involves regular, moderate-sized orders to meet consumer demand.
Government Procurement: Entities like UNICEF or national health departments may engage in tender-based purchasing of Docusate for public health programs. This segment's buying behavior is characterized by large-volume orders based on public health needs assessments.
Import regulations for Docusate vary across the top importing countries:
United States:
Regulatory Authority: Food and Drug Administration (FDA).
Import Registration Process: Importers must ensure that Docusate complies with FDA regulations, including proper labeling and adherence to Current Good Manufacturing Practices (CGMP).
Estimated Timeline for Registration: The FDA does not require pre-registration for each shipment, but compliance checks can cause delays if issues arise.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049039 are generally duty-free in the U.S.
The demand for Docusate in importing countries is influenced by several factors:
Disease Prevalence: Constipation, including opioid-induced constipation, is a common condition globally, necessitating the use of stool softeners like Docusate.
Government Healthcare Programs: Many countries have initiatives to improve access to essential medicines. For instance, the WHO's Essential Medicines List includes Docusate sodium, highlighting its importance in palliative care.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage increase the availability of essential medicines, including Docusate, to broader populations.
WHO Essential Medicines List Procurement: Inclusion in the WHO Essential Medicines List encourages countries to prioritize the procurement of Docusate for their healthcare systems.
Tender-Based Purchasing: Government and international health organizations often procure medicines through tenders, ensuring a steady demand for Docusate.
Common Questions — Docusate Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest docusate buyer importing from India?
Based on import volume and value, PL DEVELOPMENTS (UNITED STATES) leads with $5.0M in imports and a 54.3% market share — the highest of any single docusate importer. GERICARE PHARMACEUTICALS CORP. (UNITED STATES) and GENERIC HEALTH (AUSTRALIA) are the next largest buyers.
QHow many companies buy docusate from India?
There are 158 active docusate buyers importing from India, with a combined market of $9.3M across 453 shipments to 35 countries. The top 5 buyers hold 78.3% of total import value, while the remaining 153 buyers handle the other 21.7%.
QWhich countries import the most docusate from India?
The top importing countries for docusate from India are United States (84.6%), Australia (12.9%), Canada (1.5%), Venezuela (0.3%), New Zealand (0.2%). These markets represent the largest demand centres for Indian pharmaceutical exports of docusate, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for docusate from India?
The average import transaction value for docusate from India is $20.5K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
The importation of Docusate from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like PL Developments and Gericare Pharmaceuticals Corp. in the United States function as distributors. They procure Docusate in bulk to supply to pharmacies, hospitals, and retailers. Their purchasing patterns are characterized by large, consistent orders to maintain a steady supply chain.
Contract Manufacturers: Companies such as Apotex Australia and Noumed Pharmaceuticals Pty Ltd in Australia act as contract manufacturers. They import Docusate as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their procurement is aligned with production schedules and market demand forecasts, leading to periodic, substantial orders.
Retail Chains: While not explicitly listed among the top buyers, retail chains may also import Docusate directly or through intermediaries to stock their pharmacy outlets. Their purchasing behavior typically involves regular, moderate-sized orders to meet consumer demand.
Government Procurement: Entities like UNICEF or national health departments may engage in tender-based purchasing of Docusate for public health programs. This segment's buying behavior is characterized by large-volume orders based on public health needs assessments.
Import regulations for Docusate vary across the top importing countries:
United States:
Regulatory Authority: Food and Drug Administration (FDA).
Import Registration Process: Importers must ensure that Docusate complies with FDA regulations, including proper labeling and adherence to Current Good Manufacturing Practices (CGMP).
Estimated Timeline for Registration: The FDA does not require pre-registration for each shipment, but compliance checks can cause delays if issues arise.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049039 are generally duty-free in the U.S.
The demand for Docusate in importing countries is influenced by several factors:
Disease Prevalence: Constipation, including opioid-induced constipation, is a common condition globally, necessitating the use of stool softeners like Docusate.
Government Healthcare Programs: Many countries have initiatives to improve access to essential medicines. For instance, the WHO's Essential Medicines List includes Docusate sodium, highlighting its importance in palliative care.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage increase the availability of essential medicines, including Docusate, to broader populations.
WHO Essential Medicines List Procurement: Inclusion in the WHO Essential Medicines List encourages countries to prioritize the procurement of Docusate for their healthcare systems.
Tender-Based Purchasing: Government and international health organizations often procure medicines through tenders, ensuring a steady demand for Docusate.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
2Australia
Australia emerges as the second largest importing country, achieving a total trade value of $1.2M through 69 shipments. This represents a market share of 12.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Australia has a diverse importer base, with their top importers including:
• GENERIC HEALTH - $371.2K (31.0% of country's total business)
• APOTEX AUSTRALIA - $329.2K (27.5% of country's total business)
• NOUMED PHARMACEUTICALS PTY LTD - $172.6K (14.4% of country's total business)
• NOUMED PHARMACEUTICALS PTY LIMITED - $148.3K (12.4% of country's total business)
• RECKITT BENCKISER ENA B V - $64.8K (5.4% of country's total business)
• Rest of Australia's importers - $111.6K (9.3% of country's total business)
Key Insight: Australia demonstrates strong market positioning with an average shipment value of $17.4K, indicating competitive pricing strategy compared to the market average of $20.5K.
Australia is a key market for Docusate imports, representing 12.9% of total trade value.
Primary Market
Secondary Market
3Canada
Canada emerges as the third largest importing country, achieving a total trade value of $134.6K through 4 shipments. This represents a market share of 1.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• ANB CANADA INC - $134.6K (100.0% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $33.7K, indicating premium pricing strategy compared to the market average of $20.5K.
Canada is a key market for Docusate imports, representing 1.5% of total trade value.
Primary Market
Secondary Market
4Venezuela
Venezuela emerges as the fourth largest importing country, achieving a total trade value of $28.3K through 0 shipments. This represents a market share of 0.3% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Venezuela demonstrates strong market positioning with an average shipment value of $28.3K, indicating premium pricing strategy compared to the market average of $20.5K.
Venezuela is a key market for Docusate imports, representing 0.3% of total trade value.
Primary Market
Secondary Market
5New Zealand
New Zealand emerges as the fifth largest importing country, achieving a total trade value of $18.7K through 0 shipments. This represents a market share of 0.2% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: New Zealand demonstrates strong market positioning with an average shipment value of $18.7K, indicating competitive pricing strategy compared to the market average of $20.5K.
New Zealand is a key market for Docusate imports, representing 0.2% of total trade value.
Primary Market
Secondary Market
Re-exporters: Some companies may import Docusate with the intent to re-export to other markets. Their purchasing patterns depend on international demand and trade agreements.
Understanding these segments is crucial for suppliers aiming to tailor their marketing and sales strategies effectively.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Docusate must be listed in the Australian Register of Therapeutic Goods (ARTG). Importers need to provide evidence of compliance with TGA standards.
Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and TGA's assessment workload.
Import Tariff/Duty: Pharmaceuticals are typically subject to a 5% import duty, but certain agreements may reduce this rate.
Canada:
Regulatory Authority: Health Canada.
Import Registration Process: Importers must obtain a Drug Establishment License (DEL) and ensure Docusate complies with the Food and Drugs Act and Regulations.
Estimated Timeline for Registration: The DEL application process can take 6-12 months.
Import Tariff/Duty: Pharmaceutical products are generally duty-free under HS Code 30049039.
Venezuela:
Regulatory Authority: Instituto Nacional de Higiene Rafael Rangel.
Import Registration Process: Importers must register Docusate with the regulatory authority, providing documentation of quality, safety, and efficacy.
Estimated Timeline for Registration: The process can take several months, subject to regulatory review.
Import Tariff/Duty: Pharmaceuticals may be subject to import duties; specific rates should be confirmed with Venezuelan customs authorities.
New Zealand:
Regulatory Authority: Medsafe.
Import Registration Process: Docusate must be approved by Medsafe, requiring submission of a New Medicine Application (NMA).
Estimated Timeline for Registration: The approval process can take 6-12 months.
Import Tariff/Duty: Pharmaceuticals are generally duty-free under HS Code 30049039.
Importers should consult the respective regulatory authorities for the most current and detailed requirements.
TransData Nexus Research · Government and regulatory sourcesMar 2026
With 158 buyers across 35 countries, the market for Docusate is substantial and diverse, presenting significant opportunities for suppliers.
TransData Nexus Research · Government and regulatory sourcesMar 2026
$12.69 per unit
Re-exporters: Some companies may import Docusate with the intent to re-export to other markets. Their purchasing patterns depend on international demand and trade agreements.
Understanding these segments is crucial for suppliers aiming to tailor their marketing and sales strategies effectively.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Docusate must be listed in the Australian Register of Therapeutic Goods (ARTG). Importers need to provide evidence of compliance with TGA standards.
Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and TGA's assessment workload.
Import Tariff/Duty: Pharmaceuticals are typically subject to a 5% import duty, but certain agreements may reduce this rate.
Canada:
Regulatory Authority: Health Canada.
Import Registration Process: Importers must obtain a Drug Establishment License (DEL) and ensure Docusate complies with the Food and Drugs Act and Regulations.
Estimated Timeline for Registration: The DEL application process can take 6-12 months.
Import Tariff/Duty: Pharmaceutical products are generally duty-free under HS Code 30049039.
Venezuela:
Regulatory Authority: Instituto Nacional de Higiene Rafael Rangel.
Import Registration Process: Importers must register Docusate with the regulatory authority, providing documentation of quality, safety, and efficacy.
Estimated Timeline for Registration: The process can take several months, subject to regulatory review.
Import Tariff/Duty: Pharmaceuticals may be subject to import duties; specific rates should be confirmed with Venezuelan customs authorities.
New Zealand:
Regulatory Authority: Medsafe.
Import Registration Process: Docusate must be approved by Medsafe, requiring submission of a New Medicine Application (NMA).
Estimated Timeline for Registration: The approval process can take 6-12 months.
Import Tariff/Duty: Pharmaceuticals are generally duty-free under HS Code 30049039.
Importers should consult the respective regulatory authorities for the most current and detailed requirements.
TransData Nexus Research · Government and regulatory sourcesMar 2026
With 158 buyers across 35 countries, the market for Docusate is substantial and diverse, presenting significant opportunities for suppliers.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 158 global importers of Docusate identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 453 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 35 destination countries with market share per buyer calculated from capped values.
